Accession Number: | 0001894562-23-000008 |
Date: | 2023-04-18 |
Issuer: | PRIME MEDICINE, INC. (PRME) |
Original Submission Date: |
GOLDWASSER MEREDITH
C/O PRIME MEDICINE, INC.
21 ERIE STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 13.63 | 2023-04-18 | deemed execution date | A | 4,690 (a) | 2033-04-18 | common stock 4,690 | $13.63 | 4,690 | direct |
ID | footnote |
---|---|
f1 | 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of march 31, 2023, subject to the reporting person's continued service on each such vesting date. |